Your browser doesn't support javascript.
loading
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
Kim, Seok Jin; Yoon, Dok Hyun; Kang, Hye Jin; Hong, Jung Yong; Lee, Ho Sup; Oh, Sung Yong; Shin, Ho-Jin; Kong, Jee Hyun; Yi, Jun Ho; Sakamoto, Kana; Ko, Young Hyeh; Huh, Jooryung; Lee, Seung-Sook; Takeuchi, Kengo; Shin, Dong-Yeop; Suh, Cheolwon; Kim, Won Seog.
Afiliação
  • Kim SJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kang HJ; Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
  • Hong JY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee HS; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, South Korea.
  • Oh SY; Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea.
  • Shin HJ; Department of Internal Medicine, Pusan National University Hospital, Busan, South Korea.
  • Kong JH; Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, South Korea.
  • Yi JH; Department of Internal Medicine, Chung-Ang University Hospital, Seoul, South Korea.
  • Sakamoto K; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ko YH; Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Huh J; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee SS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Takeuchi K; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
  • Shin DY; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Suh C; Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kim WS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
BMC Cancer ; 19(1): 1080, 2019 Nov 10.
Article em En | MEDLINE | ID: mdl-31707975
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Doença de Hodgkin / Linfoma Difuso de Grandes Células B / Neoplasias do Mediastino Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Doença de Hodgkin / Linfoma Difuso de Grandes Células B / Neoplasias do Mediastino Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Coréia do Sul